Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 45 /hr

★★★★★

☆☆☆☆☆

Hire Pol S.

Spain

USD 45 /hr

PhD Biomedical Researcher | Oncology & Molecular Genomics | Scientific Writing & Data Analysis

Profile Summary

🎓 Biomedical Researcher | Melanoma & Cancer Biology | Translational Oncology | Molecular Genomics I am a passionate and dedicated biomedical researcher specializing in cancer biology, with a strong focus on melanoma, an aggressive and complex form of skin cancer. Throughout my career, I have aimed to dissect the mechanisms underlying tumor progression, therapy resistance, and immune evasion—applying advanced tools in molecular biology, immunology, and genomics. My PhD research at the University of Lleida – IRB Lleida focused on understanding how genomic alterations shape the tumor immune microenvironment in melanoma. I have gained extensive hands-on experience with techniques such as flow cytometry, immunohistochemistry, cell culture, animal models, PCR, ELISA, and bioinformatics tools like R, GraphPad, and QuPath. This work has led to several publications in peer-reviewed journals including British Journal of Cancer, Cancers, and Journal of Investigative Dermatology. Beyond basic science, I am committed to translational research—ensuring that laboratory discoveries lead to clinical advances. Collaborating closely with oncologists and clinical researchers has strengthened my understanding of how molecular insights can inform diagnostics, prognosis, and therapeutic strategies for melanoma patients. Currently expanding my expertise in clinical trial monitoring, I aim to bridge the gap between research and patient care. My goal is to contribute meaningfully to the development of personalized therapies and biomarker-driven approaches that improve outcomes and quality of life for cancer patients.

Subject Matter Expertise

• ☆ Biostatistics
• ☆ Human Biology
• ☆ Orthoptics
• ☆ Precision Medicine

Services

• Writing
• Research
• Data & AI

Writing Clinical Trial Documentation, Medical Writing, Non-Medical Regulatory Writing

Research Gap Analysis, Scientific and Technical Research, Systematic Literature Review

Data & AI Statistical Analysis, Image Processing, Image Analysis, Data Visualization, Data Processing

Work Experience

Clinical Trial Study Coordinator in Thoracic, Head and Neck Oncology

VHIO

2024 - Present

PhD Student

Institut de Recerca Biomèdica de Lleida Fundació Dr Pifarré

September 2018 - March 2024

Representative of PhD students

Universitat de Lleida

2020 - 2024

Internship Trainee

Barts and The London School of Medicine and Dentistry

2023 - 2023

Internship Trainee

IGTP

2021 - 2021

Education

Master in Bioinformatics and Biostatistics

Universitat Oberta de Catalunya

2021 - 2024

PhD in Health Science (Medicine )

University of Lleida

2018 - 2024

Master in Drug Research, Development and Control

Universitat de Barcelona - Institut de Biomedicina

2017 - 2018

Degree in Biotechnology

Universitat de Lleida

2013 - 2017

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

Inés de la Rosa, Pol Sisó, Christopher Ríos, Judith Gracia, Dolors Cuevas, Oscar Maiques, Núria Eritja, Xavier Soria, Joan Angel-Baldó, Sonia Gatius, et al. (2025). High Copy Number Variations Correlate with a Pro-Tumoral Microenvironment and Worse Prognosis in Acral Lentiginous Melanoma . International Journal of Molecular Sciences.

Inés de la Rosa, Pol Sisó, Christopher Ríos, Judith Gracia, Dolors Cuevas, Oscar Maiques, Núria Eritja, Xavier Soria, Joan Angel-Baldó, Sonia Gatius, et al. (2025). High Copy Number Variations Correlate with a Pro-Tumoral Microenvironment and Worse Prognosis in Acral Lentiginous Melanoma . International Journal of Molecular Sciences.

Pol Sisó, Inés de la Rosa, Christopher Ríos, Anaïs Panosa, Joan Verdaguer, RosaMaria Martí, Anna Macià (2023). Protocol to characterize the melanoma tumor immune microenvironment in mice from single cell to flow cytometry analysis . STAR Protocols.

Pol Sisó Camarasa(2022). M-CSF as a therapeutic target in BRAFV600E melanoma resistant to BRAF inhibitors . British Journal of Cancer. Springer Science and Business Media {LLC}

Pol Sisó Camarasa(2022). ARID1A‐deficient cells require HDAC6 for progression of endometrial carcinoma . Molecular Oncology. 16. (11). p. 2235--2259. Wiley

Pol Sisó Camarasa(2021). BRAFV600E Mutant Allele Frequency (MAF) Influences Melanoma Clinicopathologic Characteristics . Cancers. 13. (20). p. 5073. {MDPI} {AG}

Carla Barceló, Pol Sisó, Oscar Maiques, Sandra García-Mulero, Rebeca Sanz-Pamplona, Raúl Navaridas, Cristina Megino, Isidre Felip, Izaskun Urdanibia, Núria Eritja, et al.(2020). T-Type Calcium Channels as Potential Therapeutic Targets in Vemurafenib-Resistant BRAFV600E Melanoma . Journal of Investigative Dermatology. 140. (6). p. 1253--1265. Elsevier {BV}

Pol Sisó Camarasa(2020). T-Type Calcium Channels: A Potential Novel Target in Melanoma . Cancers. 12. (2). p. 391. {MDPI} {AG}

Pol Sisó Camarasa(2019). In vitro Cell Migration, Invasion, and Adhesion Assays: From Cell Imaging to Data Analysis . Frontiers in Cell and Developmental Biology. 7. Frontiers Media {SA}